Promis Neurosciences Valuation
| 23J Stock | EUR 10.90 2.50 18.66% |
At this time, the company appears to be overvalued. Promis Neurosciences holds a recent Real Value of €9.7 per share. The prevailing price of the company is €10.9. Our model determines the value of Promis Neurosciences from analyzing the company fundamentals such as Shares Owned By Institutions of 18.42 %, return on equity of -3.56, and Shares Outstanding of 7.2 M as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.7047 | Enterprise Value 10.8 M | Enterprise Value Ebitda (1.61) | Price Sales 4.2 K | Enterprise Value Revenue 2.2 K |
Overvalued
Today
Please note that Promis Neurosciences' price fluctuation is slightly risky at this time. Calculation of the real value of Promis Neurosciences is based on 3 months time horizon. Increasing Promis Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Promis stock is determined by what a typical buyer is willing to pay for full or partial control of Promis Neurosciences. Since Promis Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Promis Stock. However, Promis Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.9 | Real 9.7 | Hype 13.5 | Naive 15.99 |
The real value of Promis Stock, also known as its intrinsic value, is the underlying worth of Promis Neurosciences Company, which is reflected in its stock price. It is based on Promis Neurosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Promis Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Promis Neurosciences helps investors to forecast how Promis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Promis Neurosciences more accurately as focusing exclusively on Promis Neurosciences' fundamentals will not take into account other important factors: Promis Neurosciences Cash |
|
About Promis Neurosciences Valuation
The stock valuation mechanism determines Promis Neurosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Promis Neurosciences. We calculate exposure to Promis Neurosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Promis Neurosciences's related companies.ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. PROMIS NEUROSCIENCES operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5 people.
Complementary Tools for Promis Stock analysis
When running Promis Neurosciences' price analysis, check to measure Promis Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Promis Neurosciences is operating at the current time. Most of Promis Neurosciences' value examination focuses on studying past and present price action to predict the probability of Promis Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Promis Neurosciences' price. Additionally, you may evaluate how the addition of Promis Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |